ProShare Advisors
CPRX icon

ProShare Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$560K Sell
25,821
-772
-3% -$16.8K ﹤0.01% 1061
2025
Q1
$645K Sell
26,593
-7,106
-21% -$172K ﹤0.01% 973
2024
Q4
$703K Buy
33,699
+10,379
+45% +$217K ﹤0.01% 1077
2024
Q3
$464K Buy
23,320
+6,158
+36% +$122K ﹤0.01% 1180
2024
Q2
$266K Sell
17,162
-5,295
-24% -$82K ﹤0.01% 1370
2024
Q1
$358K Buy
22,457
+3,614
+19% +$57.6K ﹤0.01% 1303
2023
Q4
$317K Buy
18,843
+3,564
+23% +$59.9K ﹤0.01% 1335
2023
Q3
$179K Buy
15,279
+192
+1% +$2.24K ﹤0.01% 1503
2023
Q2
$203K Buy
15,087
+1,056
+8% +$14.2K ﹤0.01% 1532
2023
Q1
$233K Sell
14,031
-1,243
-8% -$20.6K ﹤0.01% 1363
2022
Q4
$284K Buy
15,274
+2,027
+15% +$37.7K ﹤0.01% 1271
2022
Q3
$169K Buy
13,247
+2,484
+23% +$31.7K ﹤0.01% 1443
2022
Q2
$75K Sell
10,763
-7,445
-41% -$51.9K ﹤0.01% 1655
2022
Q1
$151K Sell
18,208
-3,008
-14% -$24.9K ﹤0.01% 1951
2021
Q4
$143K Buy
21,216
+8,774
+71% +$59.1K ﹤0.01% 2137
2021
Q3
$66K Sell
12,442
-12,748
-51% -$67.6K ﹤0.01% 1953
2021
Q2
$145K Sell
25,190
-743
-3% -$4.28K ﹤0.01% 2223
2021
Q1
$120K Buy
25,933
+4,427
+21% +$20.5K ﹤0.01% 2142
2020
Q4
$72K Buy
21,506
+9,606
+81% +$32.2K ﹤0.01% 2022
2020
Q3
$35K Sell
11,900
-1,291
-10% -$3.8K ﹤0.01% 1612
2020
Q2
$61K Buy
+13,191
New +$61K ﹤0.01% 1622
2020
Q1
Sell
-13,078
Closed -$49K 1254
2019
Q4
$49K Buy
13,078
+2,089
+19% +$7.83K ﹤0.01% 1749
2019
Q3
$58K Buy
10,989
+775
+8% +$4.09K ﹤0.01% 1592
2019
Q2
$39K Sell
10,214
-273
-3% -$1.04K ﹤0.01% 1583
2019
Q1
$53K Buy
10,487
+326
+3% +$1.65K ﹤0.01% 1612
2018
Q4
$20K Sell
10,161
-1,640
-14% -$3.23K ﹤0.01% 1556
2018
Q3
$45K Sell
11,801
-904
-7% -$3.45K ﹤0.01% 1729
2018
Q2
$40K Buy
12,705
+1,521
+14% +$4.79K ﹤0.01% 1764
2018
Q1
$27K Buy
11,184
+564
+5% +$1.36K ﹤0.01% 1701
2017
Q4
$42K Buy
+10,620
New +$42K ﹤0.01% 1774
2016
Q1
Sell
-10,966
Closed -$27K 1607
2015
Q4
$27K Buy
+10,966
New +$27K ﹤0.01% 1698